Old Web
English
Sign In
Acemap
>
Paper
>
1065P Adverse events reporting in phase III oncology clinical trials of checkpoint inhibitors: A systematic review
1065P Adverse events reporting in phase III oncology clinical trials of checkpoint inhibitors: A systematic review
2020
M-L. Joulia
A. Barhli
C Tournigand
E. Kempf
Keywords:
immune checkpoint inhibitors
Clinical trial
Internal medicine
Medicine
Oncology
Adverse effect
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]